Controversies in the Management of Stage I Seminoma

ONCOLOGY

Volumn 12, Issue 8, 1998, Pages 1203-1212

  Fiveash, John ^a   Sandler, Howard M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; DRUG COST; GASTROINTESTINAL TOXICITY; HUMAN; MALE INFERTILITY; NAUSEA; PATIENT COMPLIANCE; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK BENEFIT ANALYSIS; SALVAGE THERAPY; SEMINOMA;

EID: 0031764217     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. American Cancer Society. Cancer Facts and Figures - 1997. Atlanta, American Cancer Society, 1997.
2. Horwich A, Dearnaley DP: Treatment of seminoma. Semin Oncol 19:171-180, 1992
3. Hanks GE, Herring DF, Kramer S: Patterns of Care Outcome Studies. Results of the national practice in seminoma of the testis. Int J Radiat Oncol Biol Phys 7:1413-1417, 1981
4. Fossa SD, Aass N, Kaalhus O: Radiotherapy for testicular seminoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patients Int J Radiat Oncol Biol Phys 16:383-388, 1989.
5. Dosmann MA, Zagars, GK: Postorchiectomy radiotherapy for stages I and II testicular seminoma. Int J Radiat Oncol Biol Phys 26:381- 390, 1993
6. Warde P, Gospodarowicz MK, Panzarella T, et al: Stage I testicular seminoma: Results of adjuvant irradiation and surveillance. J Clin Oncol 13: 2255-2262, 1995.
7. Dosoretz DE, Shipley WU, Blitzer PH, et al: Megavoltage irradiation for pure testicular seminoma. Cancer 48:2184-2190, 1981.
8. Lai PP, Bernstein MJ, Kim H, et al: Radiation for stage I and IIA testicular seminoma Int J Radiat Oncol Biol Phys 28:373-379, 1994.
9. Lederman GS, Herman TS, Jochelson M, et al: Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy. Radiother Oncol 14:203-208, 1989.
10. Oliver RTD, Edmonds PM, Ong JY, et al: Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma. Should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 29:3-8, 1994.
11. Ellerbroek NA, Tran LM, Selch M, et al: Testicular seminoma. Am J Clin Oncol 11:93-99, 1988.
12. Gordon W Jr, Siegmund K, Stanisic K, et al: A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy (SWOG-8711): Southwest Oncology Group. Int J Radiat Oncol Biol Phys 38:83- 94, 1997.
13. Hanks GE, Peters T, Owen J: Seminoma of the testis. Long-term beneficial and deleterious results of radiation Int J Radiat Oncol Biol Phys 24:913-919, 1992.
14. Nakfoor BM, Shipley WU, Zietman AL: Early stage testicular seminoma: The role of radiation therapy following orchiectomy. Front Radiat Ther Oncol 28:183-195, 1994
15. Wanderås EH, Fossa SD, Tretli S: Risk of a second germ cell cancer after treatment of a primary germ-cell cancer in 2201 Norwegian male patients. Eur J Cancer 33:244-252, 1997.
16. Moller H, Mellemgaard A, Jacobsen GK, et al: Incidence of second primary cancer following testicular cancer Eur J Cancer 29A:672-676, 1993.
17. Wanderås EH, Fosså SD, Tretli S: Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients. Eur J Cancer 33:253-262, 1997.
18. Travis LB, Curtis RE, Hankey BF: Second malignancies after testicular cancer (letter). J Clin Oncol 13:533-534, 1995.
19. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al: Second cancer risk following testicular cancer: A follow-up study of 1.909 patients. J Clin Oncol 11:415-424, 1993.
20. von der Maase H, Spect L, Jacobsen A, et al: Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 29A: 1931- 1934, 1993.
21. Fuks Z, Strober S, Bobrove AM, et al: Long-term effects of radiation on T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. J Clin Invest 58:803-814, 1976.
22. Horwich A, Dearnaley DP, A'Hern R, et al: The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer 28A:1307- 1310, 1992.
23. Spears WT, Morphis JG, Lester SG, et al: Brain metastases and testicular tumors: Long- term survival Int J Radiat Oncol Biol Phys 22:1992, 1992
24. Maier JG, Sulak MD, Mittemeyer BT: Seminoma of the testes: Analysis of treatment success and failure. Am J Roentgenol 102:596-602, 1968.
25. Horwich A, Alsanjari N, A'Hern R, et al: Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65:775-778, 1992.
26. Warde P, Gospodarowicz M, Panzarella T, et al. Issues in the management of stage I testicular seminoma, (ASTRO abstract 43). Int J Radiat Oncol Biol Phys 39(5): 156, 1997.
27. Ramakrishnan S, Champion A, Dorreen M, et al: Stage I seminoma of the testis: Is post- orchidectomy surveillance a safe alternative to routine postoperative radiotherapy? Clin Oncol (R Coll Radiol) 4:284-286, 1992.
28. Bassett WB, Weiss RB: Acute leukaemia following cisplatin for bladder cancer: A case report. J Clin Oncol 4:614, 1986.
29. Germa Lluch JR, Climent MA, Villavicencio H, et al: Treatment of stage I testicular tumours. Br J Urol 71:473-477, 1993
30. Allhoff EP, Liedke S, de Riese W, et al. Stage I seminoma of the testis: Adjuvant radiotherapy or surveillance? Br J Urol 68:190-194, 1991.
31. Miki T, Maeda O, Saiki S, et al: Surveillance after orchiectomy for stage I testicular seminoma. Nippon Hinyokika Gakkai Zasshi 83:1789-1794, 1992.
32. Yonese J, Kawai T, Yamauchi T, et al: Surveillance following orchiectomy for stage I testicular tumors. Nippon Hinyokika Gakkai Zasshi 84:1804-1810, 1993.
33. Charig MJ, Hindley AC, Lloyd K, et al: 'Watch policy' in patients with suspected stage I testicular seminoma: CT as a sole staging and surveillance technique. Clin Radiol 42:40-41, 1990.
34. Marks LB, Rutgers JL, Shipley WU, et al: Testicular seminoma: Clinical and pathological features that may predict paraaortic lymph node metastases. J Urol 143:524-527, 1990.
35. Naliv O, Winkler HZ, Reiman Jr HR, et al: Primary testicular seminoma: Prognostic significance of nuclear DNA ploidy pattern. Eur Urol 31:401-404, 1997.
36. Sharda NN, Kinsella TJ, Ritter MA: Adjuvant radiation vs observation: A cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 14:2933-2999, 1996.
37. Blanke CD, Delgalvis SC, Nichols GR: Late recurrence of seminoma South Med J 90:653-655, 1997.
38. Rorth M, Daugaard G: Observation and expectant management for low stage seminoma and nonseminoma, in Vogelzang NJ, Scardino FT, Shipley WU, et al (eds): Comprehensive Text- book of Genitourinary Oncology, pp 1016-1021. Baltimore, Williams and Wilkins, 1996.
39. Oliver RTD: Adjuvant cis vs carboplatin for stage I seminoma (letter). Int J Radiat Oncol Biol Phys 29:215, 1994.
40. Weissbach L, Bussar-Maatz R, Mann K: The value of tumor markers in testicular seminomas. Eur Urol 32:16-22, 1997.
41. Bulger KM, Hesketh PJ, Babayan RK: Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer. J Urol 142:1574-1575, 1989.
42. Kiricuta IC, Sauer J, Bohndorf W: Omission of the pelvic irradiation in stage I testicular seminoma. A study of postorchiectomy paraaortic radiotherapy. Int J Radiat Oncol Biol Phys 35:293-298, 1996
43. Fosså SD, Horwich A, Russell JM, et al: Optimal field size in adjuvant radiotherapy of stage I seminoma - a randomized trial (abstract) Proc Am Soc Clin Oncol 15:236, 1996.
44. Jacobsen KD, Olsen DR, Fossa K, et al: External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys 38:95-102, 1997.
45. Mason MD, Featherstone T, Olliff J, et al Inguinal and iliac lymph node involvement in germ cell tumours of the testis: Implications for radiological involvement and therapy. Clin Oncol 3: 147-150, 1991.
46. Schmidberger H, Meisner C: Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: A prospective multicenter study. Int J Radiat Oncol Biol Phys 39:321-326, 1997.
47. Coia LR, Hanks GE: Complications from large-field intermediate dose infradiaphragmatic radiation: An analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma. Int J Radiat Oncol Biol Phys 15: 29-35, 1988.
48. Dieckmann KP, Krain J, Kuster J, et al: Adjuvant carboplatin treatment for seminoma clinical stage I. J Cancer Res Clin Oncol 122:63-66, 1996.
49. Krege S, Kalund G, Otto T, et al: Phase II study: Adjuvant single-agent carboplatin therapy for clinical stage I seminoma. Eur Urol 31:405- 457, 1997.
50. Krtazik C, Kuhrer I, Wiltsche C, et al: Carboplatin-monotherapie bei seminomen in stadium i. Acta Chir Aust 25:27-28, 1993.
51. Snowden JA, Laidlaw ST, Champion AE, et al: Acute promyelocytic leukaemia after treatment for seminoma with carboplatin (letter). Lancet 344:1361, 1994.
52. Thomas GM: Surveillance in stage I seminoma of the testis. Urol Clin North Am 20:85-91, 1993.